Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Approval for Pregabalin Capsules, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg.
The above information is a part of company’s filings submitted to BSE.